|
|
|
Volumn 27, Issue 5 SUPPL. 9, 2000, Pages 1-2
|
|
Targeting progress: The development of growth factor receptor-directed therapy
a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GROWTH FACTOR RECEPTOR;
HORMONE;
MONOCLONAL ANTIBODY;
TRASTUZUMAB;
BREAST CARCINOMA;
BREAST METASTASIS;
CANCER DIAGNOSIS;
CANCER HORMONE THERAPY;
CANCER MORTALITY;
CANCER RESEARCH;
DRUG TARGETING;
HUMAN;
PRIORITY JOURNAL;
SHORT SURVEY;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
HUMAN;
RECEPTOR, ERBB-2;
|
|
EID: 0033778517
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (2)
|
|
References (0)
|